Abstract
Diamond–Blackfan anemia (DBA) is a congenital red cell aplasia arising from ribosomal protein (RP) defects. Affected patients present with neonatal anemia, occasional dysmorphism, and cancer predisposition. An anemic newborn was diagnosed with DBA due to RPL5 mutation (c.473_474del, p.K158SfsX26). Refractory anemia required regular transfusions and iron chelation therapy. Pancytopenia occurred at age 16 years. Bone-marrow studies showed myelodysplasia, erythroblastosis, and clonal evolution of del(20)(q11.2q13.3). Severe anemia required transfusions. Del(20q), including the L3MBTL1 gene, is reported to be relevant to the hematological phenotype of Shwachman–Diamond syndrome. A combined defect of RPL5 and L3MBTL1 may contribute to the aberrant erythropoiesis in the present case.
Similar content being viewed by others
Change history
02 July 2018
The corresponding author should be ‘‘Masataka Ishimura’’, and not ‘‘Motoshi Sonoda’’ as given in the original publication of the article.
References
Wegman-Ostrosky T, Savage SA. The genomics of inherited bone marrow failure: from mechanism to the clinic. Br J Haematol. 2017;177:526–42.
Ikeda F, Yoshida K, Toki T, Uechi T, Ishida S, Nakajima Y, et al. Exome sequencing identified RPS15A as a novel causative gene for Diamond–Blackfan anemia. Haematologica. 2017;102:E93–6.
Gripp KW, Curry C, Olney AH, Sandoval C, Fisher J, Chong JX, et al. Diamond–Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. Am J Med Genet Part A. 2014;164:2240–9.
Sankaran VG, Ghazvinian R, Do R, Thiru P, Vergilio JA, Beggs AH, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond–Blackfan anemia. J Clin Invest. 2012;122:2439–43.
Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142:859–76.
Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012;119:3815–9.
Dalle JH, de Latour RP. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes. Int J Hematol. 2016;103:373–9.
Gazda HT, Sheen MR, Vlachos A, Choesmel V, O’Donohue MF, Schneider H, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond–Blackfan anemia patients. Am J Hum Gene. 2008;83:769–80.
Ruggero D, Shimamura A. Marrow failure: a window into ribosome biology. Blood. 2014;124:2784–92.
Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, Swanton S, et al. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. Oncogene. 2000;19:3902–13.
Perna F, Gurvich N, Hoya-Arias R, Abdel-Wahab O, Levine RL, Asai T, et al. Depletion of L3MBTL1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q(−) polycythemia vera. Blood. 2010;116:2812–21.
Braun T, de Botton S, Taksin AL, Park S, Beyne-Rauzy O, Coiteux V, et al. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: A report on 62 cases. Leuk Res. 2011;35:863–7.
Alanio-Brechot C, Schischmanoff PO, Feneant-Thibault M, Cynober T, Tchernia G, Delaunay J, et al. Association between myeloid malignancies and acquired deficit in protein 4.1R: A retrospective analysis of six patients. Am J Hematol. 2008;83:275–8.
Babushok DV, Bessler M. Genetic predisposition syndromes: When should they be considered in the work-up of MDS? Best Pract Res Clin Haematol. 2015;28:55–68.
Nacci L, Valli R, Pinto RM, Zecca M, Cipolli M, Morini J, et al. Parental origin of the deletion del(20q) in Shwachman–Diamond patients and loss of the paternally derived allele of the imprinted L3MBTL1 gene. Genes Chromosomes Cancer. 2017;56:51–8.
Goudarzi KM, Lindstrom MS. Role of ribosomal protein mutations in tumor development (review). Int J Oncol. 2016;48:1313–24.
Fancello L, Kampen KR, Hofman IJF, Verbeeck J, De Keersmaecker K. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget. 2017;8:14462–78.
Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of diamond Blackfan anemia: an update from the Diamond Blackfan anemia registry. Pediatr Blood Cancer. 2006;46:558–64.
Roy V, Perez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R, et al. Bone marrow transplantation for Diamond–Blackfan anemia. Biol Blood Marrow Transpl. 2005;11:600–8.
Ohga S, Mugishima H, Ohara A, Kojima S, Fujisawa K, Yagi K, et al. Diamond–Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation. Int J Hematol. 2004;79:22–30.
Mugishima H, Ohga S, Ohara A, Kojima S, Fujisawa K, Tsukimoto I. Hematopoietic stem cell transplantation for Diamond–Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Pediatr Transpl. 2007;11:601–7.
Fagioli F, Quarello P, Zecca M, Lanino E, Corti P, Favre C, et al. Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014;165:673–81.
Roggero S, Quarello P, Vinciguerra T, Longo F, Piga A, Ramenghi U. Severe iron overload in Blackfan–Diamond anemia: a case–control study. Am J Hematol. 2009;84:729–32.
Acknowledgements
We thank Prof. Yoshiyuki Takahashi and Emeritus Prof. Seiji Kojima, and the staffs of the central review (Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.) for helpful comments on the BM morphology.
Funding
This work was supported in part by Practical Research Project for Rare/Intractable Diseases (15ek0109133) and Grant-in-Aids (15ek0109099h001) from the Japan Agency for Medical Research and Development (AMED) and the Research on Measures for Intractable Diseases Project and Health and Labor Sciences Research grants (Research on Intractable Diseases) from the Ministry of Health, Labor and Welfare.
Author information
Authors and Affiliations
Contributions
The contributions of each author are as follows. MS, MI, and SO were the principal investigators, taking primary responsibility for the paper. YI, ET, KE, YS and HT performed the clinical management with helpful discussion regarding the completion of the work. AH gave helpful comments on the bone-marrow findings of myelodysplasia. HK, TT, and EI completed the genetic analysis.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest to disclose.
About this article
Cite this article
Sonoda, M., Ishimura, M., Ichimiya, Y. et al. Atypical erythroblastosis in a patient with Diamond–Blackfan anemia who developed del(20q) myelodysplasia. Int J Hematol 108, 228–231 (2018). https://doi.org/10.1007/s12185-018-2424-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-018-2424-4